Reflux, Gastroesophageal Clinical Trial
Official title:
A Randomized Pilot Trial of Platelet Rich Plasma Use in Hiatal Hernia Repair
Rationale: Gastroesophageal reflux disease (GERD) is a common disease caused by a dysfunctional lower esophageal sphincter and an abnormal esophageal hiatus or hiatal hernia. Approximately 30% of large hiatal hernias will recur after surgery, in part due to weak connective tissue at the hiatus. Platelet rich plasma (PRP) is a promising autologous therapy that may address this shortcoming by substantially enhancing wound healing of the hiatus after repair. Intervention: PRP will be applied to mesh used in hiatal hernia repair. Objectives: The objective of this study is to determine the efficacy of PRP in hiatal hernia compared to traditional hernia repair without PRP. Study population: 150 patients 18 years and older with large (>5cm) paraesophageal hernias. Study methodology and study arms: a 1:1 allocation ration will be used to randomly assign 75 patients to the experimental arm (PRP with mesh) and 75 patients to the control arm (mesh only). Study outcomes: The primary outcome will be 1-year postoperative hernia recurrence based on video esophagram and/or upper endoscopy. The secondary outcome will be GERD-Health Related Quality of Life (GERD-HRQL) scores and dysphagia scores at 6 and 12 months. Follow-up: Patients who undergo fundoplication and hiatal hernia repair with mesh are seen in clinic for follow-up at two weeks, six weeks, six months, one year, and annually thereafter. Video esophagram or upper endoscopy will be performed at 1 year after surgery to assess the primary outcome. The investigators secondary outcome of reduction in GERD-HRQL score will be determined by a difference in the GERD-HRQL score from the preoperative score to the postoperative scores taken at 6 months and 1 year. The investigators secondary outcome of dysphagia will be determined by EAT-10 scores taken at 6 months and 1 year. Statistics/Analysis: Descriptive statistics will be used. Intention to treat and per protocol analyses will be performed. Frequentist and Bayesian statistical analyses will be used to determine statistically and clinically important outcomes.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05326113 -
The Effect of Physiotherapy on Post POEM Reflux
|
N/A | |
| Recruiting |
NCT05303298 -
Evaluating Acid Reflux After Oesophageal Stenting Using Anti-reflux Stents
|
N/A | |
| Recruiting |
NCT05750186 -
The Effect of Abdominal Massage Applied After Surgery
|
N/A | |
| Completed |
NCT03659487 -
Comparison of Total and Partial Fundoplication During Surgery of Patients With Gastroesophageal Reflux Disease
|
N/A | |
| Completed |
NCT05634187 -
One-stop-shop Endoscopy in Reflux-patients: Evaluation of ENT and GI Features
|
||
| Terminated |
NCT02749071 -
An Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Reflux
|
N/A | |
| Completed |
NCT04651829 -
Suspicion of Non IgE-mediated Cow's Milk Protein Allergy: Prevalence and Evolution
|
||
| Completed |
NCT00551473 -
Open-label Comparison of 24hr Gastric pH on Days 1, 2, 7 With Once-daily Administration of Lavoltidine 40 mg.
|
Phase 1 | |
| Completed |
NCT00405119 -
A Study To Investigate The Effectiveness Of AH234844 (Lavoltidine) Compared With NEXIUM And Ranitidine.
|
Phase 2 | |
| Completed |
NCT03959020 -
Applying Long-term Follow-up to Improve Patient Selection in Laparoscopic Anti-reflux Surgery
|
||
| Not yet recruiting |
NCT05425771 -
ARMA (Antireflux Mucosa Ablation) in Patients With Chronic Refractory Reflux Disease
|
N/A | |
| Recruiting |
NCT04695171 -
LINX Reflux Management System or Fundoplication Clinical Study in Patients With Hiatal Hernia >3 cm
|
||
| Completed |
NCT04344964 -
Endoscopy-related Phone Consultation During the COVID-19 Outbreak
|